Acute cardiometabolic responses facilitating a state of chronic hyperglycemia and renal impairment: The SABPA study

Cardiovascular Endocrinology

Volumn 3, Issue 3, 2014, Pages 98-106

  Joosten, Liezl ^a   Malan, Leoné ^a   Uys, Aletta S ^a   Alkerwi, Ala'A ^b   Malan, Nico T ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Africans; Albumin; Blood pressure; Creatinine; Glucose

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ACCELEROMETER; ACUTE STRESS; ADULT; AFRICAN; ALPHA ADRENERGIC STIMULATION; ARTICLE; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR RESPONSE; CAUCASIAN; CHEMICAL ANALYSIS; CHRONIC DISEASE; COLD PRESSOR TEST; CONTROLLED STUDY; ETHNIC DIFFERENCE; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; STROOP TEST; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

EID: 84954359029     PISSN: None     EISSN: 2162688X     Source Type: Journal    
DOI: 10.1097/XCE.0000000000000019     Document Type: Article

References (39)

1. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005; 112:3562-3568.
2. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93:9-30.
3. Hoebel S, Malan L, De Ridder H. Differences in MetS marker prevalence between black African and Caucasian teachers from the North West Province: Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study. J Endocrinol Metab Diab South Afr 2011; 16:49-56.
4. Naicker S. Patterns of renal disease in South Africa. Nephrology 1998; 4:21-24.
5. Obrist P. Cardiovascular psychophysiology: a perspective. New York: Plenum Press; 1981.
6. Brosius FC III, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Circulation 2006; 114:1083-1087.
7. Van Rooyen J, Kruger H, Huisman H, Wissing M, Margetts B, Venter C, Vorster H. An epidemiological study of hypertension and its determinants in a population in transition: The THUSA study. J Hum Hypertens 2000; 14:779-787.
8. Fray JCS, Douglas JG. Pathophysiology of hypertension in blacks. Oxford University Press; 1993. pp. 217-232.
9. MacArthur JD, MacArthur MC. Laboratory Tasks for Cardiovascular Reactivity Research; 2001. Available at: http://www.macses.ucsf.edu/ research/psychosocial/reactivitytable.php. [Accessed 5 May 2011].
10. Malan L, Hamer M, Schlaich MP, Lambert GL, Harvey BH, Reimann M, et al. Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study. J Hypertens 2012; 30:543-550.
11. Reimann M, Hamer M, Schlaich MP, Malan NT, Ruediger H, Ziemssen T, Malan L. Greater cardiovascular reactivity to a cold stimulus is due to higher cold pain perception in black Africans: the Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study. J Hypertens 2012; 30:2416-2424.
12. McLean JK, Sathasivam P, MacNaughton K, Graham TE. Cardiovascular and norepinephrine responses of men and women to two cold pressor tests. Can J Physiol Pharmacol 1992; 70:36-42.
13. Fairclough SH, Houston K. A metabolic measure of mental effort. Biol Psychol 2004; 66:177-190.
14. Nonogaki K, Iguchi A. Stress, acute hyperglycemia, and hyperlipidemia: role of the autonomic nervous system and cytokines. Trends Endocrinol Metab 1997; 8:192-197.
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
16. De Zeeuw D, Hillege HL, De Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int 2005; 68:25-29.
17. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28:1462-1536.
18. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15:1983-1992.
19. Mosteller RD. Simplified calculation of body surface area. New Engl J Med 1987; 317:1098.
20. Expert Committee, American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010; 33:11-61.
21. Moan A, Hoieggen A, Nordby G, Os I, Eide I, Kjeldsen SE. Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness. Metabolism 1995; 44:1303-1307.
22. Armario A, Marti O, Molina T, De Pablo J, Valdes M. Acute stress markers in humans: response of plasma glucose, cortisol and prolactin to two examinations differing in the anxiety they provoke. Psychoneuroendocrinology 1996; 21:17-24.
23. Nonogaki K, Iguchi A, Sakamoto N. Effects of adrenoceptor antagonists on the hyperthermia and hyperglycemia induced by prostaglandin F2 [alpha] in rats. Eur J Pharmacol 1994; 262:177-180.
24. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008; 57:1422-1427.
25. Feldman M, Kiser RS, Unger RH, Li CH. Beta-endorphin and the endocrine pancreas. N Engl J Med 1983; 308:349-353.
26. Lovallo W. The cold pressor test and autonomic function: a review and integration. Psychophysiology 1975; 12:268-282.
27. Malan L, Hamer M, Schlaich MP, Lambert GW, Ziemssen T, Reimann M, et al. Defensive coping facilitates higher blood pressure and early sub-clinical structural vascular disease via alterations in heart rate variability: the SABPA study. Atherosclerosis 2013; 227:391-397.
28. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54:690-697.
29. Van Lill L, Malan L, Van Rooyen J, Steyn F, Reimann M, Ziemssen T. Baroreceptor sensitivity, cardiovascular responses and ECG left ventricular hypertrophy in men: The SABPA study. Blood Press 2011; 20:355-361.
30. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of Obesity. Circulation.; 2009. pp. 1640-1645.
31. Prinsloo J, De Ridder H, Malan L, Potgieter JC. Determining the waist circumference cut off which best predicts the metabolic syndrome components in urban Africans: The SABPA study. Exp Clin Endocrinol Diabetes 2011; 119:599-603.
32. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109:2-10.
33. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43:1817-1822.
34. Volpe M, Cosentino F, Ruilope LM. Is it time to measure microalbuminuria in hypertension? J Hypertens 2003; 21:1213-1220.
35. Meigs JB, D'Agostino RB, Nathan DM, Rifai N, Wilson PWF. Longitudinal association of glycemia and microalbuminuria. Diabetes Care 2002; 25:977-983.
36. Cosentino F, Lüscher TF. Effects of blood pressure and glucose on endothelial function. Curr Hypertens Rep 2001; 3:79-88.
37. Tarsio JF, Reger LA, Furcht LT. Molecular mechanisms in basement membrane complications of diabetes: alterations in heparin, laminin, and type IV collagen association. Diabetes 1988; 37:532-539.
38. Fujita H, Narita T, Ito S. Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance. Diabetes Care 1999; 22:823-826.
39. Rehm M, Zahler S, Lötsch M, Welsch U, Conzen P, Jacob M, Becker BF. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100:1211-1223.